Qualigen Therapeutics, Inc. (NASDAQ:QLGN – Get Free Report) saw a significant increase in short interest in June. As of June 15th, there was short interest totalling 96,300 shares, an increase of 20.7% from the May 31st total of 79,800 shares. Currently, 1.6% of the shares of the stock are sold short. Based on an average daily volume of 1,130,000 shares, the days-to-cover ratio is currently 0.1 days.
Qualigen Therapeutics Stock Up 3.0 %
Qualigen Therapeutics stock opened at $0.17 on Tuesday. Qualigen Therapeutics has a 12-month low of $0.14 and a 12-month high of $1.26. The stock has a 50-day simple moving average of $0.25 and a 200 day simple moving average of $0.39.
Qualigen Therapeutics Company Profile
Further Reading
- Five stocks we like better than Qualigen Therapeutics
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Steel Dynamics Stock is Up 9.6% While Its Peers Are Rusting
- The Role Economic Reports Play in a Successful Investment Strategy
- The Top 4 Magnificent 7 Stocks to Buy in the Year’s Second Half
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Snowflake Stock Rebounds, Flies Higher on AI Spending
Receive News & Ratings for Qualigen Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qualigen Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.